Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chemokine (C-C motif) receptor 8 (CCR8) is a member of the beta chemokine receptor family and a class A G protein-coupled receptor (GPCR). It is preferentially expressed in thymus tissue, regulatory T cells (Tregs), and type 2 helper T cells (Th2). It plays a role in immune cell migration, monocyte chemotaxis, and thymic cell apoptosis. Its primary endogenous ligand is CCL1. In cancer contexts, it is upregulated on tumor-infiltrating Tregs, making it a target for cancer immunotherapy. Monoclonal antibodies targeting CCR8 are being developed to deplete intratumoral Tregs selectively.
Monoclonal antibodies targeting CCR8 deplete intratumoral Tregs, CCL1 and CCL8 act as agonists.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chemokine (C-C motif) receptor 8 (CCR8).